|
|  | Mobile Devices: | | | | | | | |
| | Associated Conditions: MAIN MENU | |
| | Autoimmune Diseases: Vasculitis | | This page was written by Shelley Ensz, and has not yet been medically edited. See Disclaimer. | | | | What is Behcet's? | | Behcet's disease is a type of vasculitis characterized by mouth sores, genital sores, inflammation inside of the eye, skin problems, and arthritis (swelling of the joints).The disease usually affects more men than women. The disease appears to be more severe in young, male, and Middle Eastern or Far Eastern patients. Vasculitis Foundation. | | Symptoms of Behcet's | | Most Common Symptoms and Signs of Behcet's Disease. Behçet's disease is not contagious; it is not spread from one person to another. The four most common symptoms (as listed) are mouth sores, genital sores, inflammation inside of the eye, and skin problems. American Behcet's Disease Association. | | The prevalence of headache in Behçet's syndrome. Recurrent headache is very common in Behçet's syndrome, is poorly treated and is associated with disablement. Rheumatology 2006 45(5):621-623. | | A case of Behcet's disease with esophageal ulcers complicated with systemic sclerosis, chronic hepatitis C, and pancytopenia. This is a rare case of Behcet's disease complicated with esophageal ulcers, systemic sclerosis, chronic hepatitis C, and pancytopenia. Of interest is the mechanism of coincidence of these diseases from the pathological point of view. PubMed. Nihon Rinsho Meneki Gakkai Kaishi. 2004 Jun;27(3):164-70.(Also see: Liver Involvement and Pancytopenia) | | Causes of Behcet's | | Behcet's Disease: Causes. Doctor's don't know what causes Behcet's disease. Many believe Behcet's disease is a form of autoimmune disorder. Behcet's disease is likely caused by a combination of genetic and environmental factors. Mayo Clinic. | | Behçet disease associated with myelodysplastic syndrome. We suggest that patients with myelodysplastic syndrome and trisomy 8 might be prone to have Behçet disease. Furthermore, more intestinal ulcers but with less eye lesions and arthritis have been noted in patients of Behçet disease with myelodysplastic syndrome than in those without myelodysplastic syndrome. (PubMed) Lin YC J Clin Rheumatol 2008 Jun;14(3):169-74. | | Behcet's disease (BD) associated with bone marrow failure (BMF) in Korean patients: clinical characteristics and the association of intestinal ulceration and trisomy 8. In four patients with refractory BD associated with BMF, successful treatment of BMF by haematopoietic stem cell transplantation resulted in clinical remission of BD. Our study indicates that intestinal ulceration is a characteristic finding in BD associated with BMF. It also suggests that cytogenetic aberration, especially trisomy 8, may play an important role in the pathogenesis of BD associated with BMF. (PubMed) Ahn JK Rheumatology (Oxford) 2008 Jun 11. | | Diagnosis of Behcet's | | Screening and Diagnosis. No tests can determine definitively whether or not you have Behcet's disease. Instead, your doctor relies primarily on your signs and symptoms to diagnose Behcet's disease. Mayo Clinic. | | Wireless capsule endoscopy (WCE) in the investigation of intestinal Behcet's syndrome. WCE technique may guide treatment and provide a better understanding of intestinal pathology in BS. S. S. Hamdulay. Rheumatology Advance Access. June 11, 2008. (Also see: GI Tests). | | Treatments for Behcet's | | Treatments for Behcet's Disease. There is no cure for Behçet's disease. Treatment typically focuses on reducing discomfort and preventing serious complications. Corticosteroids and other medications that suppress the immune system may be prescribed to treat inflammation. American Behcet's Disease Association. | | Interferon: a new therapeutic option in refractory juvenile Behçet's disease (BD) with central nervous system involvement. Recombinant human IFN- 2a (rhIFN-2a)was effective and well tolerated in these juvenile patients with severe neurological BD. J. B. Kuemmerle-Deschner. Rheumatology Advance Access. May 20, 2008. | | Interrelated modulation of endothelial function in Behcet's disease (BD) by clinical activity and corticosteroid treatment. Taken together, these results imply that corticosteroid treatment, although may deteriorate endothelial function per se during the remission phase of the inflammatory process, it restores endothelial dysfunction present during active BD, by counteracting the harmful effects of relapsing inflammation. Arthritis Research & Therapy 2007, 9:R90. | | | Keep on Surfing! |
| Go to Brain Involvement | |
| |
